Emerging Anticoagulants Regulatory Issues
{"Image DocumentName": "Emerging Anticoagulants Regulatory Issues", "Image ImageDescription": "Open-label vs. blinded trial design. Issues related to active-control trial design. How many trials are needed? Preventing use for unapproved indications. Assessing patient-oriented outcomes.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}